Skip to main content
OpenTrials

Clinical trial condition

Thoracic Neoplasms

Explore clinical trials studying Thoracic Neoplasms. Study availability and eligibility vary by location and protocol.

8,059 public trials 1,846 recruiting studies
Refine in advanced search Browse all conditions

Thoracic Neoplasms trial results

Active, not recruiting

Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations

NCT04579380

Conditions
Biliary Tract Diseases, Biliary Tract Neoplasms, Breast Diseases, +37 more
Locations
  • HonorHealth Phoenix, Arizona, United States
  • HonorHealth Tempe, Arizona, United States
  • The University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
  • City of Hope at Huntington Beach Huntington Beach, California, United States
View all 108 locations
View Trial Details
Active, not recruiting

Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer

NCT06632327

Conditions
Lung Diseases, Lung Neoplasms, Neoplasms, +8 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Fairbanks Memorial Hospital Fairbanks, Alaska, United States
  • Cancer Center at Saint Joseph's Phoenix, Arizona, United States
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
View all 411 locations
View Trial Details
Active, not recruiting

A Study to Test Different Doses of Obrixtamig in Patients With Small Cell Lung Cancer and Other Neuroendocrine Tumours That Are Positive for DLL3

NCT04429087

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Winship Cancer Institute Atlanta, Georgia, United States
  • University of Maryland School of Medicine Baltimore, Maryland, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States
View Trial Details
Active, not recruiting

Study of JDQ443 in Comparison With Docetaxel in Participants With Locally Advanced or Metastatic KRAS G12C Mutant Non-small Cell Lung Cancer

NCT05132075

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Valley Medical Center Research Renton, Washington, United States
  • Novartis Investigative Site CABA, Buenos Aires, Argentina
  • Novartis Investigative Site Pilar, Buenos Aires, Argentina
  • Novartis Investigative Site Auchenflower, Queensland, Australia
View all 51 locations
View Trial Details
Active, not recruiting

Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors

NCT04557449

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Breast Diseases, +33 more
Locations
  • Ellison Institute Los Angeles, California, United States
  • Yale-New Haven Hospital-Yale Cancer Center New Haven, Connecticut, United States
  • Smilow Cancer Hospital Phase 1 Unit New Haven, Connecticut, United States
  • Brigham & Women's Hospital Boston, Massachusetts, United States
View all 39 locations
View Trial Details
Active, not recruiting

Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)

NCT04886804

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Precision NextGen Oncology Beverly Hills, California, United States
  • City of Hope-Duarte-56419 Duarte, California, United States
  • City of Hope - Seacliff Huntington Beach, California, United States
View all 85 locations
View Trial Details
Active, not recruiting

A Study of Amivantamab and Lazertinib Combination Therapy Versus Osimertinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer

NCT04487080

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Arizona Oncology Associates, PC - HAL Goodyear, Arizona, United States
  • Yuma Regional Medical Center Yuma, Arizona, United States
  • City of Hope Long Beach Elm Long Beach, California, United States
  • University of California Irvine Orange, California, United States
View all 269 locations
View Trial Details
Active, not recruiting

A Study of Amivantamab and Lazertinib in Combination With Platinum-Based Chemotherapy Compared With Platinum-Based Chemotherapy in Patients With Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non- Small Cell Lung Cancer After Osimertinib Failure

NCT04988295

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Southern Cancer Center, PC Mobile, Alabama, United States
  • Arizona Oncology Associates Tucson, Arizona, United States
  • City of Hope Duarte, California, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
View all 249 locations
View Trial Details

Related conditions